SPAIN is getting its first doses of an American drug to help people with relapsing-remitting multiple sclerosis, which accounts for 80% of MS sufferers. Zeposia
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. ACCEPTRead more / Saber mas